Table 3.
Neonatal characteristics of infants with or without severe functional disability at 24 months.
|
Patients with severe functional disability
N = 48 |
Patients without severe functional disability
N = 454 |
Missing cases | p | |
|---|---|---|---|---|
| Birth weight, median (IQR), g | 861.5 (697.5–1,094.5) | 1,104 (895–1,360) | – | <0.001 |
| Gestational age, median (IQR), wk | 26.9 (25.3–29) | 29.5 (27.7–31.3) | – | <0.001 |
| Outborn, n (%) | 4 (8.3) | 15 (3.3) | – | 0.082 |
| Ethnicity (Not-Hispanic), n (%) | 3 (6.3) | 15 (3.3) | – | 0.300 |
| Multiple gestation, n (%) | 13 (27.1) | 159 (35.0) | – | 0.270 |
| Apgar 5th min, median (IQR) | 9 (7–9) | 9 (8–9) | – | 0.038 |
| Male gender, n (%) | 31 (64.6) | 220 (48.5) | – | 0.034 |
| Prenatal steroids exposure, n (%) | 44 (91.7) | 414 (92) | 4 | 0.936 |
| Chorioamnionitis, n (%) | 16 (33.3) | 83 (18.3) | 1 | 0.013 |
| Sepsis, n (%) | 14 (29.2) | 40 (8.8) | – | <0.001 |
| Mechanical ventilation, n (%) | 33 (68.8) | 157 (34.6) | – | <0.001 |
| Periventricular-intraventricular hemorrhage, n (%) | 18 (39.1) | 55 (12.1) | 2 | <0.001 |
| Periventricular leukomalacia, n (%) | 7 (15.2) | 5 (1.1) | 2 | <0.001 |
| PDA pharmacological treatment, n (%) | 20 (41.7) | 110 (24.2) | – | 0.009 |
| PDA surgical treatment, n (%) | 9 (19.2) | 21 (4.8) | 15 | <0.001 |
| Necrotizing enterocolitis, n (%) | 5 (10.4) | 13 (2.9) | – | 0.007 |
| ROP surgical treatment, n (%) | 8 (16.7) | 6 (1.3) | – | <0.001 |
| Human milk feeding at discharge, n (%) | 22 (45.8) | 320 (70.8) | – | <0.001 |
PDA, patent ductus arteriosus; ROP, retinopathy of the prematurity.
Missing cases were excluded from the statistical analyses.
The values in bold are statistically significant (p < 0.05).